The antimicrobial resistance monitoring and research (ARMoR) program: the US Department of Defense response to escalating antimicrobial resistance.

Responding to escalating antimicrobial resistance (AMR), the US Department of Defense implemented an enterprise-wide collaboration, the Antimicrobial Resistance Monitoring and Research Program, to aid in infection prevention and control. It consists of a network of epidemiologists, bioinformaticists, microbiology researchers, policy makers, hospital-based infection preventionists, and healthcare providers who collaborate to collect relevant AMR data, conduct centralized molecular characterization, and use AMR characterization feedback to implement appropriate infection prevention and control measures and influence policy. A particularly concerning type of AMR, carbapenem-resistant Enterobacteriaceae, significantly declined after the program was launched. Similarly, there have been no further reports or outbreaks of another concerning type of AMR, colistin resistance in Acinetobacter, in the Department of Defense since the program was initiated. However, bacteria containing AMR-encoding genes are increasing. To update program stakeholders and other healthcare systems facing such challenges, we describe the processes and impact of the program.

[1]  Robert J. Clifford,et al.  A multidrug-resistance surveillance network: 1 year on. , 2012, The Lancet. Infectious diseases.

[2]  E. Lesho,et al.  Optically Mapping Multiple Bacterial Genomes Simultaneously in a Single Run , 2011, PloS one.

[3]  Robert J. Clifford,et al.  Novel 16S rRNA Methyltransferase RmtH Produced by Klebsiella pneumoniae Associated with War-Related Trauma , 2013, Antimicrobial Agents and Chemotherapy.

[4]  Detection of New Delhi Metallo-β-Lactamase (Encoded by bla NDM-1) in Acinetobacter schindleri during Routine Surveillance , 2013, Journal of Clinical Microbiology.

[5]  E. Lesho,et al.  Methicillin-resistant Staphylococcus aureus infection in combat support hospitals in three regions of Iraq , 2010, Epidemiology and Infection.

[6]  Neil Gupta,et al.  Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Robert J. Clifford,et al.  Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections. , 2013, The Journal of infectious diseases.

[8]  Arjun Srinivasan,et al.  Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010 , 2013, Infection Control & Hospital Epidemiology.

[9]  Zhining Wang,et al.  Gram-Negative Multidrug-Resistant Organism Colonization in a US Military Healthcare Facility in Iraq , 2011, Infection Control & Hospital Epidemiology.

[10]  Paige E. Waterman,et al.  Detection of qacA/B in Clinical Isolates of Methicillin-Resistant Staphylococcus aureus from a Regional Healthcare Network in the Eastern United States , 2011, Infection Control & Hospital Epidemiology.

[11]  K. Laupland,et al.  Surveillance for antimicrobial resistant organisms: potential sources and magnitude of bias , 2009, Epidemiology and Infection.

[12]  Robert J. Clifford,et al.  Enhanced De Novo Assembly of High Throughput Pyrosequencing Data Using Whole Genome Mapping , 2013, PloS one.

[13]  Paige E. Waterman,et al.  Rapid and Simultaneous Detection of bla KPC and bla NDM by Use of Multiplex Real-Time PCR , 2013, Journal of Clinical Microbiology.

[14]  E. Lesho,et al.  Detection of Bacterial 16S rRNA and Identification of Four Clinically Important Bacteria by Real-Time PCR , 2012, PloS one.

[15]  Gupta Ekta,et al.  Klebsiella pneumoniae Antimicrobial Drug Resistance, United States, 1998–2010 , 2013, Emerging infectious diseases.

[16]  Paige E. Waterman,et al.  Surveillance, characterisation, and preservation of multidrug-resistant bacteria. , 2011, The Lancet. Infectious diseases.

[17]  E. Lesho,et al.  Amount of Usage and Involvement in Explosions Not Associated with Increased Contamination of Prehospital Vehicles with Multi-drug-resistant Organisms , 2013, Prehospital and Disaster Medicine.

[18]  E. Lesho,et al.  Complete Sequence of a Novel 178-Kilobase Plasmid Carrying blaNDM-1 in a Providencia stuartii Strain Isolated in Afghanistan , 2012, Antimicrobial Agents and Chemotherapy.

[19]  M. Landrum,et al.  Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010. , 2012, JAMA.

[20]  D. Monnet,et al.  Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[21]  Robert J. Clifford,et al.  Bacterial Peritonitis Due to Acinetobacter baumannii Sequence Type 25 with Plasmid-Borne New Delhi Metallo-β-Lactamase in Honduras , 2013, Antimicrobial Agents and Chemotherapy.

[22]  E. Lesho,et al.  Complete Genome Sequence of Providencia stuartii Clinical Isolate MRSN 2154 , 2012, Journal of bacteriology.

[23]  Margaret A Dudeck,et al.  Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014 , 2016, Infection Control & Hospital Epidemiology.

[24]  E. Lesho,et al.  Joint collaboration enhances infection control at home and abroad: the maiden voyage of the multidrug-resistant organism repository and surveillance network. , 2011, Military medicine.

[25]  J. Bartlett,et al.  Seven ways to preserve the miracle of antibiotics. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  Paige E. Waterman,et al.  Rapid and simultaneous detection of the chlorhexidine and mupirocin resistance genes qacA/B and mupA in clinical isolates of methicillin-resistant Staphylococcus aureus. , 2013, Diagnostic microbiology and infectious disease.